This webinar will update on CLL second-line treatments today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should individuals expect in their care decisions.
We’ll seek to explain the different types of intensive and non-intensive treatments, who can have a particular therapy, how they work, their efficacy and impact on daily living.
We will be joined by
- Dr Tahla Munir, Consultant in Clinical Haematology at Leeds Teaching Hospitals NHS Trust. Dr Munir’s main clinical and research special interests are in chronic lymphocytic leukaemia, particularly in the assessment of the mechanism of action of novel targeted therapies.
- Lianne Palmer, CLL-specific CNS at Oxford University Hospitals. Lianne Palmer is one of just a handful of CLL-specific clinical nurse specialists across the UK.
- Two individuals with experience of CLL.
Please note, we will not be able to give individual medical advice. You will be directed to your own clinical team if we cannot answer your question in the webinar.
Due to the large amount of registrants, we cannot guarantee that everyone's questions will be answered, but we will try and do our best in the time frame that we have.
Joining the webinar
The webinar is being hosted on Zoom, and means you can ask questions during the webinar. To join via Zoom, all you need to do is register your attendance before the webinar starts. You will then receive an email inviting you to join the webinar on the day.
Never used Zoom before?
If you haven't used Zoom before, you might like to join the webinar a few minutes early to ensure you can get connected. You can also see our guide for how to join a Zoom webinar.